- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
7th grade Avg
|
- 10-K Annual report
- 10.12 Amended and Restated 1995 Stock Option Plan
- 10.13 Amended and Restated 1998 Stock Option Plan
- 10.14 Amended and Restated 2000 Stock Option Plan
- 10.15 Amended/restated 2001 Employee Stock Option Plan
- 10.16 Amended and Restated 2002 Stock Option Plan
- 10.17 Amended and Restated 2004 Stock Incentive Plan
- 10.26 Amendment #1 to $350M Credit Agreement
- 10.27 Amendment #2 to $350M Credit Agreement
- 10.29 Amendment #1 to $400M Credit Agreement
- 13 Portions of 2005 Annual Report to Shareholders
- 21 Subsidiaries of the Registrant
- 23 Consent of Ernst & Young LLP
- 24 Power of Attorney
- 31.1 Certification of CEO Pursuant to Section 302
- 31.2 Certification of CFO Pursuant to Section 302
- 32.1 Certification of CEO Pursuant to Section 906
- 32.2 Certification of CFO Pursuant to Section 906
Exhibit 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Annual Report (Form 10-K) of St. Jude Medical, Inc. of our reports dated February 16, 2006, with respect to the consolidated financial statements of St. Jude Medical, Inc., St. Jude Medical, Inc. management’s assessment of the effectiveness of internal control over financial reporting, and the effectiveness of internal control over financial reporting of St. Jude Medical, Inc., included in the 2005 Annual Report to Shareholders of St. Jude Medical, Inc.
Our audits also included the financial statement schedule of St. Jude Medical, Inc. listed in Item 15(a)(2). This schedule is the responsibility of St. Jude Medical, Inc.’s management. Our responsibility is to express an opinion based on our audits. In our opinion, as to which the date is February 16, 2006, the financial statement schedule referred to above, when considered in relation to the basic financial statements taken as a whole, presents fairly in all material respects the information set forth therein.
We also consent to the incorporation by reference in the Registration Statement No. 33-9262, Registration Statement No. 33-41459, Registration Statement No. 33-48502, Registration Statement No. 33-54435, Registration Statement No. 333-42945, Registration Statement No. 333-42658, Registration Statement No. 333-42668, Registration Statement No. 333-96697, Registration Statement No. 333-127381 and Registration Statement No. 333-130180 on Form S-8 of St. Jude Medical, Inc. of our reports dated February 16, 2006, with respect to the consolidated financial statements of St. Jude Medical, Inc., St. Jude Medical, Inc. management’s assessment of the effectiveness of internal control over financial reporting, and the effectiveness of internal control over financial reporting of St. Jude Medical, Inc., incorporated herein by reference, and our report included in the preceding paragraph with respect to the financial statement schedule of St. Jude Medical, Inc. included in this Annual Report (Form 10-K) of St. Jude Medical, Inc.
/s/ Ernst & Young LLP
Minneapolis, MN
March 10, 2006